News | Magnetic Resonance Imaging (MRI) | February 28, 2020

Dry Magnet MRI System for Molecular Imaging

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020

MR Solutions’ dry magnet MRI system for molecular imaging on display at EMIM 2020

February 28, 2020 — MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI (with PET or SPECT) and new benchtop PET/CT systems to the imaging science community at the 15th European Molecular Imaging Meeting (EMIM 2020) on March 24-27, 2020 in Thessaloniki, Greece. 

Fabrice Chaumard, MR Solution’s sales and marketing director commented: “Our very latest compact scanners with multi-modality imaging techniques will be on display at EMIM. These systems offer better performance at a very competitive cost and do not require helium top-ups. We will be welcoming visitors to Booth #104 to show off our state of the art range of MRI/PET/SPECT/CT technology with interchangeable cradles to speed-up and minimise handling.”

MR Solutions’ preclinical MRI systems offer superior soft tissue contrast and molecular imaging capability for great visualisation, quantification and translational studies. Because the molecular imaging systems are compact they do not need a reinforced concrete floor, Faraday cage, liquid helium, or special height requirement for the room. They can also be installed next to other scanners and other sensitive equipment as their stray magnetic field is a few centimetres compared to metres with liquid helium cooled systems.

MR Solutions’ MRI and CT technology can be combined with PET or SPECT imaging modules for either simultaneous or sequential imaging (dependent on the chosen configuration).

The EMIM is an annual event organized by the European Society for Molecular Imaging. The programme allows researchers to discuss and share knowledge within the molecular imaging community and to take a look at emerging technologies.

MR Solutions works closely with leading academic institutions across the world to be at the cutting edge of performance. Its own research, development and assembly of the scanners is carried out in the UK with 99% of their orders being exported to the world’s leading academic and research institutions.

MR Solutions’ dry magnet, preclinical MRI systems have been recognized with prestigious award wins including three Queen’s Awards for Enterprise – for innovation in 2016 and 2019 and for international trade in 2017.

For more information: www.mrsolutions.com

Related Content

Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress".

Unhealthy lifestyles, various diseases, stress, and aging can all contribute to an imbalance between the production of ROS and the body's ability to reduce and eliminate them. The resulting excessive levels of ROS cause "oxidative stress". Graphic courtesy of National Institutes for Quantum and Radiological Science and Technology

News | Magnetic Resonance Imaging (MRI) | February 10, 2021
February 10, 2021 — Oxygen is essential for human life, but within the body, certain biological environmental conditi
Phase III clinical trial of men with a clinical suspicion of prostate cancer finds MRI with targeted biopsies to be more accurate at diagnosis and less intrusive than current standard
News | Magnetic Resonance Imaging (MRI) | February 08, 2021
February 8, 2021 — The results of a Phase III randomized clinical trial have shown that when it comes to detecting cl
Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients. Image courtesy of Farrokh Dehdashti

Bright spots indicate that cancer cells have responded to a one-day challenge with estrogen in this positron emission tomography (PET) scan of a woman with breast cancer. In a small study, researchers at Washington University School of Medicine in St. Louis found that only women whose tumors responded to estrogen challenge benefited from hormone therapy. The findings could help doctors choose the treatments most likely to help their patients. Image courtesy of Farrokh Dehdashti

News | PET Imaging | February 03, 2021
February 3, 2021 — Hormone therapy commonly is given as a targeted treatment for women whose cancer cells carry recep

Beckman researcher, Brad Sutton (Photo courtesy the Beckman Institute)

News | Magnetic Resonance Imaging (MRI) | February 01, 2021
February 1, 2021 — Researchers at the Beckman Institute for Ad...
Most research on sleep is conducted using electroencephalography (EEG), a method that entails measuring brain activity through electrodes placed along a patient's scalp. However, Anjali Tarun, a doctoral assistant at EPFL's Medical Image Processing Laboratory within the School of Engineering, decided to investigate brain activity during sleep using magnetic resonance imaging, or MRI.

Getty Images

News | Magnetic Resonance Imaging (MRI) | January 26, 2021
January 26, 2021 — Our state of consciousness changes significantly during stages of deep sleep, just as it does in a
Steinberg Diagnostic Medical Imaging headquarters.

Steinberg Diagnostic Medical Imaging headquarters.

Sponsored Content | Case Study | Contrast Media Injectors | January 21, 2021
Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years a